Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13476 - 13500 of 14350 in total
AT-GTX-502 is an experimental, one-time gene therapy that uses AAV9 to deliver a functional copy of CLN3.
Investigational
Experimental
Withdrawn
AMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.
Investigational
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
ALM201 is an anti-angiogenic synthetic peptide identified from the endogenous human protein, FKBPL. It is being investigated in the treatment of various cancers.
Investigational
Investigational
Investigational
Investigational
Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
Investigational
Investigational
BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells.
Investigational
Investigational
Displaying drugs 13476 - 13500 of 14350 in total